Scholar Rock Holding (SRRK) Interest Expenses (2024 - 2026)
Scholar Rock Holding's quarterly Interest Expenses came in at $2.3 million in Q1 2026, up 26.62% year-on-year from $1.8 million in Q1 2025, and down 9.16% quarter-over-quarter from $2.5 million in Q4 2025.
Scholar Rock Holding has reported Interest Expenses for 3 years, with the latest figure at $2.3 million in Q1 2026.
- For the quarter ending Q1 2026, Interest Expenses rose 26.62% year-over-year to $2.3 million; the trailing twelve-month figure through Mar 2026 stood at $7.4 million (up 6.54% YoY), and the FY2025 full-year result was $6.9 million, up 0.82% from the prior year.
- Interest Expenses for Q1 2026 stood at $2.3 million, down from $2.5 million in the prior quarter.
- The five-year high for Interest Expenses was $2.5 million in Q4 2025, with the low at $1.2 million in Q2 2025.
- Average Interest Expenses over 3 years is $1.8 million, with a median of $1.7 million recorded in 2024.
- Peak annual rise in Interest Expenses reached 53.95% in 2025, while the deepest fall reached 29.68% in 2025.
- Tracing SRRK's Interest Expenses over 3 years: stood at $1.6 million in 2024, then soared by 53.95% to $2.5 million in 2025, then slipped by 9.16% to $2.3 million in 2026.
- The last three Interest Expenses figures came in at $2.3 million (Q1 2026), $2.5 million (Q4 2025), and $1.3 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Interest Expense (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | 22,854.00 |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | -5.50 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | 61,000.00 |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | - |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | -332,000.00 |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | 12.90 Mn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 69.29 Mn |
| 10 | Scholar Rock Holding | 500.61 Mn | 20.67 Mn | - | 2.30 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 2.30 Mn |
| Mar 31, 2026 | 2.30 Mn |
| Dec 31, 2025 | 2.53 Mn |
| Dec 31, 2025 | 2.53 Mn |
| Sep 30, 2025 | 1.33 Mn |
| Sep 30, 2025 | 1.33 Mn |
| Jun 30, 2025 | 1.21 Mn |
| Jun 30, 2025 | 1.21 Mn |
| Mar 31, 2025 | 1.82 Mn |
| Mar 31, 2025 | 1.82 Mn |
| Dec 31, 2024 | 1.65 Mn |
| Dec 31, 2024 | 1.65 Mn |
| Sep 30, 2024 | 1.74 Mn |
| Sep 30, 2024 | 1.74 Mn |
| Jun 30, 2024 | 1.72 Mn |
| Jun 30, 2024 | 1.72 Mn |
| Mar 31, 2024 | 1.73 Mn |
| Mar 31, 2024 | 1.73 Mn |